Kidney Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Therapeutic Dilemma (or Not)?

被引：11
作者：
Noris, Marina [1 ]
Ruggenenti, Piero [2 ]
Remuzzi, Giuseppe [1 ,2 ,3 ]
机构：
[1] IRCCS Ist Ric Farmacol Mario Negri, Clin Res Ctr Rare Dis Aldo & Cele Dacco Ranica, Bergamo, Italy
[2] Azienda Sociosanit Terr ASST Papa Giovanni XXIII, Bergamo, Italy
[3] Univ Milan, Milan, Italy
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2017年 / 70卷 / 06期
关键词：
RENAL-TRANSPLANTATION; C3; MUTATION; ECULIZUMAB; RECURRENCE; GENE; AHUS; DEFICIENCY; RECIPIENTS; HUS;
D O I：
10.1053/j.ajkd.2017.08.005
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：754 / 757
页数：4
相关论文
共 27 条
  • [1] America's Health Insurance Plans, 2016, HIGH PRIC EST ANN PA
  • [2] Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: Prognostic significance-of genetic background
    Bresin, Elena
    Daina, Erica
    Noris, Marina
    Castelletti, Federica
    Stefanov, Rumen
    Hill, Prudence
    Goodship, Timothy H. J.
    Remuzzi, Giuseppe
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (01): : 88 - 99
  • [3] Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype
    Bresin, Elena
    Rurali, Erica
    Caprioli, Jessica
    Sanchez-Corral, Pilar
    Fremeaux-Bacchi, Veronique
    Rodriguez de Cordoba, Santiago
    Pinto, Sheila
    Goodship, Timothy H. J.
    Alberti, Marta
    Ribes, David
    Valoti, Elisabetta
    Remuzzi, Giuseppe
    Noris, Marina
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (03): : 475 - 486
  • [4] Complement Alternative Pathway Deficiency in Recipients Protects Kidney Allograft From Ischemia/Reperfusion Injury and Alloreactive T Cell Response
    Casiraghi, F.
    Azzollini, N.
    Todeschini, M.
    Fiori, S.
    Cavinato, R. A.
    Cassis, P.
    Solini, S.
    Pezzuto, F.
    Mister, M.
    Thurman, J. M.
    Benigni, A.
    Remuzzi, G.
    Noris, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (09) : 2312 - 2325
  • [5] Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series
    Duineveld, Caroline
    Verhave, Jacobien C.
    Berger, Stefan P.
    van de Kar, Nicole C. A. J.
    Wetzels, Jack F. M.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 70 (06) : 770 - 777
  • [6] Pathogenic Variants in Complement Genes and Risk of Atypical Hemolytic Uremic Syndrome Relapse after Eculizumab Discontinuation
    Fakhouri, Fadi
    Fila, Marc
    Provot, Francois
    Delmas, Yahsou
    Barbet, Christelle
    Chatelet, Valerie
    Rafat, Cedric
    Cailliez, Mathilde
    Hogan, Julien
    Servais, Aude
    Karras, Alexandre
    Makdassi, Raifah
    Louillet, Feriell
    Coindre, Jean-Philippe
    Rondeau, Eric
    Loirat, Chantal
    Fremeaux-Bacchi, Veronique
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (01): : 50 - 59
  • [7] Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
    Goodship, Timothy H. J.
    Cook, H. Terence
    Fakhouri, Fadi
    Fervenza, Fernando C.
    Fremeaux-Bacchi, Veronique
    Kavanagh, David
    Nester, Carla M.
    Noris, Marina
    Pickering, Matthew C.
    de Cordoba, Santiago Rodriguez
    Roumenina, Lubka T.
    Sethi, Sanjeev
    Smith, Richard J. H.
    [J]. KIDNEY INTERNATIONAL, 2017, 91 (03) : 539 - 551
  • [8] Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome
    Greenbaum, Larry A.
    Fila, Marc
    Ardissino, Gianluigi
    Al-Akash, Samhar I.
    Evans, Jonathan
    Henning, Paul
    Lieberman, Kenneth V.
    Maringhini, Silvio
    Pape, Lars
    Rees, Lesley
    van de Kar, Nicole C. A. J.
    Vande Walle, Johan
    Ogawa, Masayo
    Bedrosian, Camille L.
    Licht, Christoph
    [J]. KIDNEY INTERNATIONAL, 2016, 89 (03) : 701 - 711
  • [9] Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS
    Grenda, Ryszard
    Jarmuzek, Wioletta
    Rubik, Jacek
    Prokurat, Sylwester
    Miklaszewska, Monika
    Drozdz, Dorota
    Zachwieja, Katarzyna
    Ardissino, Gianluigi
    Hofer, Johannes
    [J]. PEDIATRIC TRANSPLANTATION, 2015, 19 (06) : E130 - E134
  • [10] Kaths JM, 2017, TRANSPLANT REV
123